Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 viruses.
about
Antiviral resistance and the control of pandemic influenzaA randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combinationPassive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in miceAvian influenza virus (H5N1): a threat to human health.Identification of PTCH1 requirement for influenza virus using random homozygous gene perturbationSynthetic long oligonucleotides to generate artificial templates for use as positive controls in molecular assays: drug resistance mutations in influenza virus as an examplePyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity.Quantification of the anti-influenza drug zanamivir in plasma using high-throughput HILIC-MS/MS.Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice.The use of antiviral drugs for influenza: recommended guidelines for practitioners.Antiviral resistance in influenza viruses circulating in Central and South America based on the detection of established genetic markers.Findings from a household randomized controlled trial of hand washing and face masks to reduce influenza transmission in Bangkok, ThailandSurveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.Theoretical aspects of immunity.
P2860
Q28469119-E4CF670C-C8A4-4D7A-B4A8-6B2B4329104BQ28471710-0A18016E-42E7-4BAB-BE0B-85CFA08ACE5CQ30357432-7CE18108-7AE1-413F-A10A-C4047668AD87Q30361041-82250B05-53FF-41B5-811B-01C39D95EE7DQ30383129-FF956C88-FA2D-40D2-A492-2541D03CF3FAQ30405988-97B35518-ADFE-4C32-855B-894E993E84C7Q33533629-4C1CA74C-DFDD-4932-842E-95A5BD49A055Q34988176-454A1643-902E-46C0-904E-CE021085B7A2Q35647695-610B78DE-0729-449E-99BC-89D57CE55D9CQ36171279-7B991496-373C-4DC9-9011-C84C831144C1Q36252371-5FAEA6EE-C2FD-4F44-A26D-1EB72C38E091Q36252462-3EB4C9F6-9868-4749-A43D-33E40FDB5C29Q36870919-52C960F4-33A1-4391-ACCC-FBF2CF8D9B3DQ37995258-20E0D952-DCBB-433D-8993-8C18A5BDE073
P2860
Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 viruses.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Neuraminidase inhibitor suscep ...... e in influenza A/H5N1 viruses.
@ast
Neuraminidase inhibitor suscep ...... e in influenza A/H5N1 viruses.
@en
type
label
Neuraminidase inhibitor suscep ...... e in influenza A/H5N1 viruses.
@ast
Neuraminidase inhibitor suscep ...... e in influenza A/H5N1 viruses.
@en
prefLabel
Neuraminidase inhibitor suscep ...... e in influenza A/H5N1 viruses.
@ast
Neuraminidase inhibitor suscep ...... e in influenza A/H5N1 viruses.
@en
P2093
P50
P1433
P1476
Neuraminidase inhibitor suscep ...... ce in influenza A/H5N1 viruses
@en
P2093
Alan Hampson
Alexander Klimov
Amold Monto
Catherine Macken
Jennifer McKimm-Breschkin
Maria Zambon
Masato Tashiro
Michèle Amyard
P304
P577
2005-01-01T00:00:00Z